InnoHK@HKU / Centre for Immunology & Infection

Health@INNOHK

Centre for Immunology & Infection

Centre for Immunology & Infection (C2i) addresses significant public healthcare challenges through the establishment of a novel technology platform for biomarker discovery and the development of new vaccine and therapeutic strategies. The Centre enhances Hong Kong’s knowledge-based economy and provides state-of-the-art training for the local population.

Visit Our Website

MANAGING DIRECTOR

Professor Leo POON

Professor and Division Head, Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Co-Director of the HKU-Pasteur Research Pole
Principal Investigator, Centre for Immunology & Infection
Expert in various Working Groups of the World Health Organisation for emerging viruses
BSc(HKBU), MPhil(CUHK), DPhil(Oxon), FFPH (UK)

CO-Director

Professor Malik PEIRIS

2021 Future Science Prize in Life Sciences
Tam Wah-Ching Professor in Medical Science
Professor, Chair of Virology, Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Honorary Director of the HKU-Pasteur Research Pole
MBBS, FRCPath, D Phil (Oxon), FHKAM (Path), FRCP, FRS

Co-Director

Professor Roberto BRUZZONE

Professor, The Institut Pasteur
Visiting Professor, Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Co-Director of the HKU-Pasteur Research Pole
Chair of the International Severe Acute Respiratory & Emerging Infection Consortium (ISARIC)
MD

News Centre

Filter

All Types

Time Period

Apply

All Types

Corporate News

Press Release

Media Articles

Insights

Job Vacancies

Others

No results found.

Sorry, the filter combination has no results.
Please try different criteria.

We are actively hiring

Our R&D Centres are actively looking for talents. Check back from time to time to see the constantly updated job vacancies that would be the right fit for you.

Laboratory of Data Discovery for Health, Centre for Transformative Garment Production, Hong Kong Quantum AI Lab, Advanced Biomedical Instrumentation Centre, Centre for Immunology & Infection, Centre for Oncology and Immunology, Centre for Translational Stem Cell Biology, Laboratory for Synthetic Chemistry and Chemical Biology, Centre for Virology, Vaccinology and Therapeutics

Job Vacancies

05 Jul 2023

C2i featured on RTHK’s I&T New Era II

Video Source: RTHK
Focusing the Healthy Human Global Project - Hong Kong conducted by C2i, this episode gives an insight into individual immune responses, sharing why every person appears to have a unique immune system. As an R&D centre under InnoHK, a major initiative of the Hong Kong SAR, C2i adopts innovative strategies to confront and mitigate the impact of emerging infectious diseases and transform Hong Kong and the Greater Bay Area into a global hub of knowledge and research.

Centre for Immunology & Infection

Media Articles

27 Jan 2023

Eighteen InnoHK@HKU scientists listed among most highly cited researchers in 2022

We proudly congratulate our scientists who are recognized as Highly Cited Researchers by Clarivate for 2022. Their works have been highly cited by fellow academics and are hence making a significant impact on ongoing research in their respective fields of study.

Laboratory of Data Discovery for Health, Centre for Immunology & Infection, Centre for Oncology and Immunology, Centre for Virology, Vaccinology and Therapeutics

Corporate News

18 Nov 2022

HKU President visits InnoHK@HKU R&D Centres’ laboratories

Professor Xiang ZHANG, President and Vice-Chancellor of the University of Hong Kong, visited some of our R&D Centres’ laboratories at the Hong Kong Science and Technology Park.

Advanced Biomedical Instrumentation Centre, Centre for Immunology & Infection, Centre for Translational Stem Cell Biology, Laboratory for Synthetic Chemistry and Chemical Biology, Centre for Virology, Vaccinology and Therapeutics

Corporate News

28 Sep 2022

We are actively hiring

Our R&D Centres are actively looking for talents. Check back from time to time to see the constantly updated job vacancies that would be the right fit for you.

Job Vacancies

14 Jul 2022

C2i and HKU lead way to benchmark immune health and shape future of precision medicine

Centre for Immunology & Infection is launching the Healthy Human Global Project - Hong Kong to help improve local and global public health and create the next generation of personalized care and precision medical interventions.

Centre for Immunology & Infection

Press Release

21 Jun 2022

InnoHK Launch Ceremony marks milestone in promoting HK’s I&T development

InnoHK Launch Ceremony was held today (May 25) at the Hong Kong Science and Technology Parks (HKSTP). It marked a milestone in the Hong Kong Special Administrative Region (HKSAR) Government's commitment to promoting Hong Kong's innovation and technology (I&T).

Corporate News

25 May 2022

Omicron variant can multiply 70 times faster than other strains in lower respiratory tracts of hosts

South China Morning Post reports Michael Chan and team findings and warns the overall threat could be “very significant”, although there could be lower infection severity.

Centre for Immunology & Infection

Media Articles

16 Dec 2021

Development of the world’s first stainless steel that kills the COVID19 virus within hours

Leo Poon and the Department of Mechanical Engineering (HKU) developed the world's first stainless steel that kills the COVID19 virus within hours.

Centre for Immunology & Infection

Corporate News

08 Dec 2021

HKU has the greatest share of nine research laboratories admitted to the Government’s InnoHK Research Clusters

The University of Hong Kong (HKU) is playing a leading role in InnoHK, a major initiative of the Hong Kong Government to develop Hong Kong as a hub for global research.
Nine research laboratories, the most among local universities, are established at HKU with a funding of over $3 billion over five years.

Press Release

14 Oct 2021

Congratulations Professor Peiris!

We are very proud to share that Professor Malik Peiris won the Future Science Prize in life sciences alongside Professor Yuen Kwok-yung(HKUMed) for the discoveries of SARS-CoV-1 as the causative agent for the global SARS outbreak in 2003 and its zoonotic origin, with impact on combating COVID-19!

Centre for Immunology & Infection

Others

13 Sep 2021

Leo Poon to coordinate major UGC funded TRS 2021/2022 Project

The University Grant Council has announced the results of the Theme-based Research Scheme 2021/22 funding approval on 13 July with eight research proposals awarded total funding of $415 million.

Centre for Immunology & Infection

Press Release

13 Jul 2021

New Study Compares Antibody Level in BioNTech and Sinovac Vaccine Recipients

Co-signed by Malik Peiris in the Lancet Microbe, the study has found that recipients of the BioNTech COVID-19 vaccine have 10 times more antibodies than those who took Sinovac.

Centre for Immunology & Infection

Others

12 May 2021

Interview of Michael Chan for RTHK

RTHK came to C2i to ask Dr Michael Chan questions about his recent breakthrough study on Simeprevir as a potent treatment for COVID-19.

Centre for Immunology & Infection

Media Articles

12 May 2021

First participants vaccinated in HKU trial to test COVID-19 vaccines in healthy adolescents

Investigators of the Department of Paediatrics and Adolescent Medicine and the School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, are now launching the COVID-19 Vaccination in Adolescents (COVA) study. 300 healthy adolescents aged 11 years or above and their parents will be offered one of the COVID-19 vaccines available in Hong Kong of their choosing.

Centre for Immunology & Infection

Press Release

11 May 2021

Welcome to C2i!

Guided by Malik Peiris, Managing Director, and Roberto Bruzzone, Co-Director, C2i’s guests, including Mr Alexandre Giorgini, Consul General of France in Hong Kong and Macau, Prof. John Kao, Head of Biomedical Technology Cluster (HKSTP), and Mr Hailson Yu, COO of HKU Innovation Holdings Limited

Centre for Immunology & Infection

Others

30 Apr 2021

Health@INNOHK /

Centre for Immunology & Infection

Next Centre